Quadrant Capital Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Quadrant Capital Group's ABMD Position: Q4 2022 in Review
Quadrant Capital Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 231 shares — an estimated $57K sold.
Quadrant Capital Group first reported a position in ABMD in Q1 2016 and held it in 27 quarters. The position peaked at $81K in Q1 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Quadrant Capital Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Quadrant Capital Group sold 231 Abiomed Inc shares in Q4 2022, an estimated $57K.
- Quadrant Capital Group first reported a position in Abiomed Inc in Q1 2016 and held it in 27 quarters.
- Quadrant Capital Group's Abiomed Inc position peaked at $81K in Q1 2019.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Quadrant Capital Group's 13F filing for Q4 2022, filed 13 Feb 2023.